Vagotomy and gastric tumorigenesis

Current Neuropharmacology

Volumn 14, Issue 8, 2016, Pages 967-972

  Rabben, Hanne Line ^a   Zhao, Chun Mei ^a   Hayakawa, Yoku ^b   Wang, Timothy C ^b   Chen, Duan ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Howard Hughes Medical Institute   (United States)

Author keywords

Botulinum toxin A; Denervation; Gastric cancer; Muscarinic receptors; Stem cell signaling; Vagus nerve

Indexed keywords

BOTULINUM TOXIN A; CIMETIDINE; MUSCARINIC RECEPTOR; NEUROTRANSMITTER; SNARE PROTEIN;

CANCER RECURRENCE; CARCINOGENESIS; CLINICAL TRIAL (TOPIC); DENERVATION; DYSPLASIA; ENTEROCHROMAFFIN LIKE CELL; GASTRIC HYPOACIDITY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HYPERGASTRINEMIA; NONHUMAN; PARTIAL GASTRECTOMY; PEPTIC ULCER; PYLOROPLASTY; REVIEW; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH EMPTYING; TRUNCUS VAGOTOMY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY; ADVERSE EFFECTS; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; STOMACH NEOPLASMS; VAGOTOMY;

ANIMALS; CARCINOGENESIS; HUMANS; STOMACH NEOPLASMS; VAGOTOMY;

EID: 85010422727     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X14666160121114854     Document Type: Review

References (62)

1. Modlin, I.M. From Prout to the proton pump-a history of the science of gastric acid secretion and the surgery of peptic ulcer. Surg. Gynecol. Obstet., 1990, 170(1), 81-96.
2. Skandalakis, L.J.; Gray, S.W.; Skandalakis, J.E. The history and surgical anatomy of the vagus nerve. Surg. Gynecol. Obstet., 1986, 162(1), 75-85.
3. Woodward, E.R. The history of vagotomy. Am. J. Surg., 1987, 153(1), 9-17. [http://dx.doi.org/10.1016/0002-9610(87)90195-4]
4. Yeo, C.J. Md.; Matthews, J.B. Md.; Mcfadden, D.W. Md.; Pemberton, J.H. Md.; Peters, J.H. Md.. Shackelford's Surgery of the Alimentary Tract, 7th ed; Elsevier: Philadelphia, 2013, p 57.
5. Mistiaen, W.; Van Hee, R.; Bortier, H. Current status of proximal gastric vagotomy, one hundred years after Pavlov: is it finally history? Acta Chir. Belg, 2005, 105(2), 121-126.
6. Lundell, L. Acid secretion and gastric surgery. Dig. Dis., 2011, 29(5), 487-490. [http://dx.doi.org/10.1159/000331516]
7. Møller, H.; Nissen, A.; Mosbech, J. Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. Gut, 1992, 33(9), 1166-1169. [http://dx.doi.org/10.1136/gut.33.9.1166]
8. Lundegårdh, G.; Ekbom, A.; McLaughlin, J.K.; Nyrén, O. Gastric cancer risk after vagotomy. Gut, 1994, 35(7), 946-949. [http://dx.doi.org/10.1136/gut.35.7.946]
9. Graham, D.Y. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J. Gastroenterol., 2014, 20(18), 5191-5204. [http://dx.doi.org/10.3748/wjg.v20.i18.5191]
10. Graham, D.Y. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology, 2015, 148 (4), 719-31.e3. [http://dx.doi.org/10.1053/j.gastro.2015.01.040]
11. Colin-Jones, D.G.; Langman, M.J.; Lawson, D.H.; Vessey, M.P. Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br. Med. J. (Clin. Res. Ed), 1985, 291 (6502), 1084-1088. [http://dx.doi.org/10.1136/bmj.291.6502.1084]
12. La Vecchia, C.; Negri, E.; D’Avanzo, B.; Franceschi, S.; Franceschi, S. Histamine-2-receptor antagonists and gastric cancer risk. Lancet, 1990, 336(8711), 355-357. [http://dx.doi.org/10.1016/0140-6736(90)91888-H]
13. Schumacher, M.C.; Jick, S.S.; Jick, H.; Feld, A.D. Cimetidine use and gastric cancer. Epidemiology, 1990, 1(3), 251-254. [http://dx.doi.org/10.1097/00001648-199005000-00012]
14. Moayyedi, P.; Leontiadis, G.I. The risks of PPI therapy. Nat. Rev. Gastroenterol. Hepatol., 2012, 9(3), 132-139. [http://dx.doi.org/10.1038/nrgastro.2011.272]
15. Olbe, L.; Carlsson, E.; Lindberg, P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nat. Rev. Drug Discov., 2003, 2(2), 132-139. [http://dx.doi.org/10.1038/nrd1010]
16. Graham, D.Y.; Genta, R.M. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr. Gastroenterol. Rep., 2008, 10(6), 543-547. [http://dx.doi.org/10.1007/s11894-008-0100-1]
17. Han, Y.M.; Park, J.M.; Kangwan, N.; Jeong, M.; Lee, S.; Cho, J.Y.; Ko, W.J.; Hahm, K.B. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin. J. Physiol. Pharmacol., 2015, 66(2), 159-167.
18. Reimer, C. Safety of long-term PPI therapy. Best Pract. Res. Clin. Gastroenterol., 2013, 27(3), 443-454. [http://dx.doi.org/10.1016/j.bpg.2013.06.001]
19. Waldum, H.L.; Hauso, Ø.; Fossmark, R. The regulation of gastric acid secretion - clinical perspectives. Acta Physiol. (Oxf), 2014, 210(2), 239-256. [http://dx.doi.org/10.1111/apha.12208]
20. Hansson, L.E.; Nyrén, O.; Hsing, A.W.; Bergström, R.; Josefsson, S.; Chow, W.H.; Fraumeni, J.F., Jr; Adami, H.O. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med., 1996, 335(4), 242-249. [http://dx.doi.org/10.1056/NEJM199607253350404]
21. Brinton, L.A.; Gridley, G.; Hrubec, Z.; Hoover, R.; Fraumeni, J.F., Jr Cancer risk following pernicious anaemia. Br. J. Cancer, 1989, 59(5), 810-813. [http://dx.doi.org/10.1038/bjc.1989.169]
22. Caygill, C.P.; Hill, M.J.; Kirkham, J.S.; Northfield, T.C. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet, 1986, 1(8487), 929-931. [http://dx.doi.org/10.1016/S0140-6736(86)91041-X]
23. Duthie, H.L.; Kwong, N.K. Vagotomy or gastrectomy for gastric ulcer. BMJ, 1973, 4(5884), 79-81. [http://dx.doi.org/10.1136/bmj.4.5884.79]
24. Møller, H.; Toftgaard, C. Cancer occurrence in a cohort of patients surgically treated for peptic ulcer. Gut, 1991, 32(7), 740-744. [http://dx.doi.org/10.1136/gut.32.7.740]
25. Sipponen, P.; Kekki, M.; Haapakoski, J.; Ihamäki, T.; Siurala, M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer, 1985, 35(2), 173-177. [http://dx.doi.org/10.1002/ijc.2910350206]
26. Watt, P.C.; Patterson, C.C.; Kennedy, T.L. Late mortality after vagotomy and drainage for duodenal ulcer. Br. Med. J. (Clin. Res. Ed), 1984, 288(6427), 1335-1338. [http://dx.doi.org/10.1136/bmj.288.6427.1335]
27. Ware, J.; Corcoran, G.D.; Day, D.W.; O’Donnell, C.M.; Newton, C.J.; Taylor, W.H. An investigation of possible risk factors associated with gastric cancer after benign ulcer operations. IARC Sci. Publ., 1987, (84), 531-533.
28. Caygill, C.P.; Hill, M.J.; Hall, C.N.; Kirkham, J.S.; Northfield, T.C. Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut, 1987, 28(8), 924-928. [http://dx.doi.org/10.1136/gut.28.8.924]
29. Tatsuta, M.; Iishi, H.; Yamamura, H.; Baba, M.; Taniguchi, H. Effects of bilateral and unilateral vagotomy on gastric carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Int. J. Cancer, 1988, 42(3), 414-418. [http://dx.doi.org/10.1002/ijc.2910420318]
30. Tatsuta, M.; Yamamura, H.; Iishi, H.; Ichii, M.; Noguchi, S.; Baba, M.; Taniguchi, H. Promotion by vagotomy of gastric carcino-genesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res., 1985, 45(1), 194-197
31. Axelson, J.; Ekelund, M.; Håkanson, R.; Sundler, F. Gastrin and the vagus interact in the trophic control of the rat oxyntic mucosa. Regul. Pept., 1988, 22(3), 237-243. [http://dx.doi.org/10.1016/0167-0115(88)90036-5]
32. Ericsson, P.; Håkanson, R.; Rehfeld, J.F.; Norlén, P. Gastrin release: Antrum microdialysis reveals a complex neural control. Regul. Pept., 2010, 161(1-3), 22-32. [http://dx.doi.org/10.1016/j.regpep.2010.01.004]
33. Håkanson, R.; Axelson, J.; Tielemans, Y.; Johansson, A.G.; Willems, G.; Sundler, F. Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach. Scand. J. Gastroenterol., 1992, 27(1), 65-70. [http://dx.doi.org/10.3109/00365529209011169]
34. Koh, T.J.; Chen, D. Gastrin as a growth factor in the gastrointestinal tract. Regul. Pept., 2000, 93(1-3), 37-44. [http://dx.doi.org/10.1016/ S0167-0115(00)00176-2]
35. Aihara, T.; Fujishita, T.; Kanatani, K.; Furutani, K.; Nakamura, E.; Taketo, M.M.; Matsui, M.; Chen, D.; Okabe, S. Impaired gastric secretion and lack of trophic responses to hypergastrinemia in M3 muscarinic receptor knockout mice. Gastroenterology, 2003, 125(6), 1774-1784. [http://dx.doi.org/10.1053/j.gastro.2003.09.018]
36. Cassaro, M.; Rugge, M.; Gutierrez, O.; Leandro, G.; Graham, D.Y.; Genta, R.M. Topographic patterns of intestinal metaplasia and gastric cancer. Am. J. Gastroenterol., 2000, 95(6), 1431-1438. [http://dx.doi.org/10.1111/j.1572-0241.2000.02074.x]
37. Correa, P.; Cuello, C.; Duque, E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J. Natl. Cancer Inst., 1970, 44(2), 297-306.
38. Zhao, C.M.; Hayakawa, Y.; Kodama, Y.; Muthupalani, S.; Westphalen, C.B.; Andersen, G.T.; Flatberg, A.; Johannessen, H.; Friedman, R.A.; Renz, B.W.; Sandvik, A.K.; Beisvag, V.; Tomita, H.; Hara, A.; Quante, M.; Li, Z.; Gershon, M.D.; Kaneko, K.; Fox, J.G.; Wang, T.C.; Chen, D. Denervation suppresses gastric tumorigenesis. Sci. Transl. Med., 2014, 6(250), 250ra115. [http://dx.doi.org/10.1126/scitranslmed.3009569]
39. Cui, G.; Koh, T.J.; Chen, D.; Zhao, C.M.; Takaishi, S.; Dockray, G.J.; Varro, A.; Rogers, A.B.; Fox, J.G.; Wang, T.C. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res., 2004, 64(22), 8160-8166. [http://dx.doi.org/10.1158/0008-5472.CAN-04-0876]
40. Hayakawa, Y.; Jin, G.; Wang, H.; Chen, X.; Westphalen, C.B.; Asfaha, S.; Renz, B.W.; Ariyama, H.; Dubeykovskaya, Z.A.; Takemoto, Y.; Lee, Y.; Muley, A.; Tailor, Y.; Chen, D.; Muthupalani, S.; Fox, J.G.; Shulkes, A.; Worthley, D.L.; Takaishi, S.; Wang, T.C. CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut, 2015, 64(4), 544-553. [http://dx.doi.org/10.1136/gutjnl-2014-307190]
41. Stenström, B.; Zhao, C.M.; Rogers, A.B.; Nilsson, H.O.; Sturegård, E.; Lundgren, S.; Fox, J.G.; Wang, T.C.; Wadström, T.M.; Chen, D. Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice. Carcinogenesis, 2007, 28(9), 2041-2046. [http://dx.doi.org/10.1093/carcin/bgm071]
42. Vigen, R.A.; Kodama, Y.; Viset, T.; Fossmark, R.; Waldum, H.; Kidd, M.; Wang, T.C.; Modlin, I.M.; Chen, D.; Zhao, C.M. Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patients. Histol. Histopathol., 2013, 28(4), 531-542
43. Weissmann, G.; Collins, T.; Evers, A.; Dunham, P. Membrane perturbation: studies employing a calcium-sensitive dye, arsenazo III, in liposomes. Proc. Natl. Acad. Sci. USA, 1976, 73(2), 510-514. [http://dx.doi.org/10.1073/pnas.73.2.510]
44. Chen, D.; Stenström, B.; Zhao, C.M.; Wadström, T. Does Helicobacter pylori infection per se cause gastric cancer or duodenal ulcer? Inadequate evidence in Mongolian gerbils and inbred mice. FEMS Immunol. Med. Microbiol., 2007, 50(2), 184-189. [http://dx.doi.org/10.1111/j.1574-695X.2007.00249.x]
45. Gutkind, J.S.; Novotny, E.A.; Brann, M.R.; Robbins, K.C. Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc. Natl. Acad. Sci. USA, 1991, 88(11), 4703-4707. [http://dx.doi.org/10.1073/pnas.88.11.4703]
46. Salmanian, S.; Najafi, S.M.; Rafipour, M.; Arjomand, M.R.; Shahheydari, H.; Ansari, S.; Kashkooli, L.; Rasouli, S.J.; Jazi, M.S.; Minaei, T. Regulation of GSK-3beta and beta-Catenin by Galphaq in HEK293T cells. Biochem. Biophys. Res. Commun., 2010, 395(4), 577-582. [http://dx.doi.org/10.1016/j.bbrc.2010.04.087]
47. Xie, G.; Drachenberg, C.; Yamada, M.; Wess, J.; Raufman, J.P. Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 289(3), G521-G529. [http://dx.doi.org/10.1152/ajpgi.00105.2004]
48. Jobling, P.; Pundavela, J.; Oliveira, S.M.; Roselli, S.; Walker, M.M.; Hondermarck, H. Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. Cancer Res., 2015, 75(9), 1777-1781. [http://dx.doi.org/10.1158/0008-5472.CAN-14-3180]
49. Magnon, C.; Hall, S.J.; Lin, J.; Xue, X.; Gerber, L.; Freedland, S.J.; Frenette, P.S. Autonomic nerve development contributes to prostate cancer progression. Science, 2013, 341(6142), 1236361. [http://dx.doi.org/10.1126/science.1236361]
50. Brownell, I.; Guevara, E.; Bai, C.B.; Loomis, C.A.; Joyner, A.L. Nerve-derived sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell, Rabben et al. 2011, 8(5), 552-565. [http://dx.doi.org/10.1016/j.stem.2011.02.021]
51. Hanoun, M.; Zhang, D.; Mizoguchi, T.; Pinho, S.; Pierce, H.; Kunisaki, Y.; Lacombe, J.; Armstrong, S.A.; Dührsen, U.; Frenette, P.S. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell, 2014, 15(3), 365-375. [http://dx.doi.org/10.1016/j.stem.2014.06.020]
52. Katayama, Y.; Battista, M.; Kao, W.M.; Hidalgo, A.; Peired, A.J.; Thomas, S.A.; Frenette, P.S. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell, 2006, 124(2), 407-421. [http://dx.doi.org/10.1016/j.cell.2005.10.041]
53. Knox, S.M.; Lombaert, I.M.; Reed, X.; Vitale-Cross, L.; Gutkind, J.S.; Hoffman, M.P. Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis. Science, 2010, 329(5999), 1645-1647. [http://dx.doi.org/10.1126/science.1192046]
54. Peterson, S.C.; Eberl, M.; Vagnozzi, A.N.; Belkadi, A.; Veniaminova, N.A.; Verhaegen, M.E.; Bichakjian, C.K.; Ward, N.L.; Dlugosz, A.A.; Wong, S.Y. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell, 2015, 16(4), 400-412. [http://dx.doi.org/10.1016/j.stem.2015.02.006]
55. Liebl, F.; Demir, I.E.; Mayer, K.; Schuster, T.; D’haese, J.G.; Becker, K.; Langer, R.; Bergmann, F.; Wang, K.; Rosenberg, R.; Novotny, A.R.; Feith, M.; Reim, D.; Friess, H.; Ceyhan, G.O. The Impact of Neural Invasion Severity in Gastrointestinal Malignancies: A Clinicopathological Study. Ann. Surg., 2014, 260(5), 900-907. [http://dx.doi.org/10.1097/SLA.0000000000000968]
56. Venkatesh, H.S.; Johung, T.B.; Caretti, V.; Noll, A.; Tang, Y.; Nagaraja, S.; Gibson, E.M.; Mount, C.W.; Polepalli, J.; Mitra, S.S.; Woo, P.J.; Malenka, R.C.; Vogel, H.; Bredel, M.; Mallick, P.; Monje, M. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion. Cell, 2015, 161(4), 803-816. [http://dx.doi.org/10.1016/j.cell.2015.04.012]
57. Ulloa, F.; Gonzàlez-Juncà, A.; Meffre, D.; Barrecheguren, P.J.; Martínez-Mármol, R.; Pazos, I.; Olivé, N.; Cotrufo, T.; Seoane, J.; Soriano, E. Blockade of the SNARE protein syntaxin 1 inhibits glioblastoma tumor growth. PLoS One, 2015, 10(3), e0119707. [http://dx.doi.org/10.1371/journal.pone.0119707]
58. Shah, N.; Khurana, S.; Cheng, K.; Raufman, J.P. Muscarinic receptors and ligands in cancer. Am. J. Physiol. Cell Physiol., 2009, 296(2), C221-C232. [http://dx.doi.org/10.1152/ajpcell.00514.2008]
59. Takebe, N.; Miele, L.; Harris, P.J.; Jeong, W.; Bando, H.; Kahn, M.; Yang, S.X.; Ivy, S.P. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat. Rev. Clin. Oncol., 2015, 12(8), 445-464. [http://dx.doi.org/10.1038/nrclinonc.2015.61]
60. Martelli, D.; McKinley, M.J.; McAllen, R.M. The cholinergic antiinflammatory pathway: a critical review. Auton. Neurosci, 2014, 182, 65-69. [http://dx.doi.org/10.1016/j.autneu.2013.12.007]
61. Rosas-Ballina, M.; Olofsson, P.S.; Ochani, M.; Valdés-Ferrer, S.I.; Levine, Y.A.; Reardon, C.; Tusche, M.W.; Pavlov, V.A.; Andersson, U.; Chavan, S.; Mak, T.W.; Tracey, K.J.; Acetylcholine-Synthesizing, T. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science, 2011, 334(6052), 98-101. [http://dx.doi.org/10.1126/science.1209985]
62. Fuentes, J.M.; Hanly, E.J.; Aurora, A.R.; De Maio, A.; Talamini, M.A. Anesthesia-specific protection from endotoxic shock is not mediated through the vagus nerve. Surgery, 2005, 138(4), 766-771. [http://dx.doi.org/10.1016/j.surg.2005.06.057]